Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Organic Chemistry >  Carboxylic acids and derivatives >  Ethyl trans-4-Hydroxycyclohexanecarboxylate

Ethyl trans-4-Hydroxycyclohexanecarboxylate

Basic information Safety Supplier Related

Ethyl trans-4-Hydroxycyclohexanecarboxylate Basic information

Product Name:
Ethyl trans-4-Hydroxycyclohexanecarboxylate
Synonyms:
  • 4-HYDROXY-CYCLOHEXANECARBOXYLIC ACID ETHYL ESTER
  • Ethyl trans-4-Hydroxycyclohexanecarboxylate
  • ethyl (1r,4r)-4-hydroxycyclohexane-1-carboxylate
  • trans-4-Hydroxycyclohexanecarboxylic Acid Ethyl Ester
  • trans-Ethyl 4-hydroxycyclohexanecarboxylate
  • 3618-04-0, 17159-80-7, 75877-66-6
  • 3618-04-0, 75877-66-6, 17159-80-7
  • Ethyl trans-4-hydroxycyclohexane-1-carboxylate
CAS:
3618-04-0
MF:
C9H16O3
MW:
172.22
Mol File:
3618-04-0.mol
More
Less

Ethyl trans-4-Hydroxycyclohexanecarboxylate Chemical Properties

Boiling point:
144°C/12mmHg(lit.)
Density 
1.093±0.06 g/cm3(Predicted)
refractive index 
1.4630 to 1.4670
storage temp. 
Sealed in dry,Room Temperature
form 
clear liquid
pka
14.98±0.40(Predicted)
color 
Colorless to Almost colorless
InChI
InChI=1S/C9H16O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h7-8,10H,2-6H2,1H3/t7-,8-
InChIKey
BZKQJSLASWRDNE-ZKCHVHJHSA-N
SMILES
[C@@H]1(C(OCC)=O)CC[C@@H](O)CC1
More
Less

Safety Information

HS Code 
2918199890
More
Less

Ethyl trans-4-Hydroxycyclohexanecarboxylate Usage And Synthesis

Uses

trans-Ethyl 4-hydroxycyclohexanecarboxylate acts as a reagent in the discovery of Mer kinase inhibitors for the treatment of pediatric acute lymphoblastic leukemia, in the structural activity relationship study of piperidine-based derivatives as novel influenza virus inhibitors.

Synthesis

17159-79-4

3618-04-0

To a solution of ethyl 4-oxocyclohexanecarboxylate (13.5 g, 79 mmol) in methanol (150 mL) at 0 °C was slowly added sodium borohydride (5.3 g, 140 mmol). The reaction mixture was stirred continuously for 3 hours at room temperature. Upon completion of the reaction, the reaction was quenched by the addition of water (50 mL) followed by extraction with ethyl acetate (150 mL x 1, 50 mL x 2). The organic phases were combined, washed with water (50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (eluent ratio: hexane-ethyl acetate 1.5:1 to 1:1) to afford ethyl trans-4-hydroxycyclohexanecarboxylate (12 g, 88% yield, cis-trans ratio = 3:7) as a colorless transparent oil.1H NMR (300 MHz, CDCl3, cis-trans mixture) δ: 4.17-4.08 (m, 2H), 3.90 ( bs, 0.3H), 3.68-3.57 (m, 0.7H), 2.42-1.28 (m, 9H), 1.27-1.22 (m, 3H) ppm.(Hydroxyl signal was not observed.)

References

[1] Journal of Medicinal Chemistry, 2016, vol. 59, # 19, p. 8967 - 9004
[2] Organic Process Research and Development, 2010, vol. 14, # 4, p. 883 - 889
[3] Patent: WO2005/80317, 2005, A2. Location in patent: Page/Page column 150
[4] Tetrahedron Letters, 2000, vol. 41, # 39, p. 7567 - 7570
[5] Patent: US5175290, 1992, A

Ethyl trans-4-HydroxycyclohexanecarboxylateSupplier

Taizhou Elitechemie MediPharma Technology Co., Ltd. Gold
Tel
523-86810021 18921709486
Email
gwli@elitechemie.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com